Tradestie Institutional Equity Comparison Engine

NUVB vs OLMA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NUVB Overall Edge

NUVB Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nuvation Bio Inc. (NUVB) driven by superior Momentum & Technical, Options & Structure while OLMA counters with relative strength in Growth & Margin. Fundamentally, NUVB trades at N/M Forward P/E with -61.2% operating margin (+242.6% YoY revenue) versus OLMA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NUVB sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro) against OLMA sits in BREAKDOWN (31st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NUVB N/M vs OLMA N/M Fwd P/E
Growth & Margin Winner OLMA
Op Margin -61.2% vs 0.0% ยท YoY +242.6% vs +0.0%
Momentum & Technical Winner NUVB
1Y -46.9% vs -63.9% ยท 52W Pos 2% vs 3%
Options & Structure Winner NUVB
BREAKDOWN (26th %ile IV) vs BREAKDOWN (31st %ile IV)
NUVB NYSE
Nuvation Bio Inc.
Pharmaceutical Preparations
$3.80
-0.26% 1D
Market Cap $1.3B
1M Return -19.15%
1Y Return -46.85%
Forward P/E N/M
Unified AI Score
61.0 / 100 BUY
Tech 53.0 Fund 61.0 Flow 67.0 Mom 64.0
OLMA NASDAQ
Olema Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$7.02
-1.82% 1D
Market Cap $626.4M
1M Return +0.0%
1Y Return -63.87%
Forward P/E N/M
Unified AI Score
39.9 / 100 SELL
Tech 38.0 Fund 50.0 Flow 65.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NUVB -46.85% OLMA -63.87% Spread: +17.02 pp (NUVB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NUVB TTM Op. Margin: -61.2% OLMA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NUVB vs OLMA. Trailing 12-month operating profitability (NUVB -61.2% vs OLMA 0.0%) and valuation multiples (NUVB N/M vs OLMA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NUVB (5) vs OLMA (3)
Institutional Metric NUVB OLMA Criterion Row Winner
Market Capitalization Scale $1.3B $626.4M Larger Scale NUVB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +242.6% +0.0% Higher Growth NUVB
Operating Margin (TTM) Profitability -61.2% 0.0% Higher Margin OLMA
Net Profit Margin Profitability -67.4% 0.0% Higher Margin OLMA
Return on Equity (ROE) Capital Efficiency -49.1% -69.8% Higher ROE NUVB
52-Week Range Position Momentum 2% ($4โ€“$10) 3% ($6โ€“$36) Stronger Trend OLMA
Beta / 30D Volatility Risk Regime 1.52ฮฒ ยท 55% Vol 1.57ฮฒ ยท 83% Vol Lower Realized Risk NUVB
Unified Institutional Score Composite Signal 61.0 / 100 (BUY) 39.9 / 100 (SELL) Higher Composite NUVB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NUVB vs OLMA Buy Guide
NUVB BREAKDOWN
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NUVB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OLMA BREAKDOWN
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 31st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live OLMA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NUVB nor OLMA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.